Skip to content
2000
image of Oxidative Stress and Inflammatory Markers of Cordocentesis Blood in Response to Fetal Anemia

Abstract

Background

Hypothetically, fetal anemic hypoxia causes cellular damage with an increase in oxidative stress levels. This study, using hemoglobin (Hb) Bart’s disease as a study model, aims to compare the levels of oxidative stress and inflammatory markers as well as fetal hemodynamics in anemic fetuses with those of non-anemic fetuses.

Materials and Methods

Forty pregnancies at risk of fetal Hb Bart’s disease scheduled for cordocentesis at 18 to 22 weeks were recruited into the study. Fetal blood was collected to measure the levels of 8-Isoprostane (8-Isop), tumor necrosis factor-alpha (TNF-α), interleukin-10 (IL-10), and hemoglobin as well as for hemoglobin typing.

Results

There was no significant difference in cord blood 8-Isop, TNF-α, and IL-10 levels between the Hb Bart’s disease group and the unaffected group, whereas several hemodynamic parameters, such as cardiac output, cardiac size, cardiac performance, middle cerebral artery – peak systolic velocity, ., were significantly changed in the fetal Hb Bart’s group. In the subgroup analysis, the level of serum 8-Isop in the severe anemia group tended to increase, though not significantly, compared with the non-anemic group (275.3±141.8 vs. 203.9±49.2 pg/mL; p=0.079).

Conclusion

In response to anemia, fetuses might have a high capacity of hemodynamic adaptation without significant cellular damage, though a trend of an increase in oxidative stress marker was found in severe fetal anemia. Theoretically, intrauterine blood transfusion for fetal anemia during adaptive compensation may result in no residual insults.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cmm/10.2174/1573405617666210204211744
2025-07-14
2025-11-01

  • From This Site

    /content/journals/cmm/10.2174/1573405617666210204211744
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Stamatas G.N. Morello A.P. Mays D.A. Early inflammatory processes in the skin. Curr. Mol. Med. 2013 13 8 1250 1269 10.2174/15665240113139990047 23448341
    [Google Scholar]
  2. Frijhoff J. Winyard P.G. Zarkovic N. Clinical Relevance of Biomarkers of Oxidative Stress. Antioxid. Redox Signal. 2015 23 14 1144 1170 10.1089/ars.2015.6317 26415143
    [Google Scholar]
  3. Chiang W.L. Hsieh Y.S. Yang S.F. Lu T.A. Chu S.C. Differential expression of glutathione-S-transferase isoenzymes in various types of anemia in Taiwan. Clin. Chim. Acta 2007 375 1-2 110 114 10.1016/j.cca.2006.06.023 16904091
    [Google Scholar]
  4. Matayatsuk C. Lee C.Y. Kalpravidh R.W. Elevated F2-isoprostanes in thalassemic patients. Free Radic. Biol. Med. 2007 43 12 1649 1655 10.1016/j.freeradbiomed.2007.08.026 18037130
    [Google Scholar]
  5. Tselepis A.D. Hahalis G. Tellis C.C. Plasma levels of lipoprotein-associated phospholipase A(2) are increased in patients with β-thalassemia. J. Lipid Res. 2010 51 11 3331 3341 10.1194/jlr.M007229 20625038
    [Google Scholar]
  6. Hirsch R.E. Sibmooh N. Fucharoen S. Friedman J.M. HbE/β-Thalassemia and Oxidative Stress: The Key to Pathophysiological Mechanisms and Novel Therapeutics. Antioxid. Redox Signal. 2017 26 14 794 813 10.1089/ars.2016.6806 27650096
    [Google Scholar]
  7. Fibach E. Dana M. Oxidative Stress in β-Thalassemia. Mol. Diagn. Ther. 2019 23 2 245 261 10.1007/s40291‑018‑0373‑5 30484264
    [Google Scholar]
  8. Cheng M.L. Ho H.Y. Tseng H.C. Lee C.H. Shih L.Y. Chiu D.T. Antioxidant deficit and enhanced susceptibility to oxidative damage in individuals with different forms of alpha-thalassaemia. Br. J. Haematol. 2005 128 1 119 127 10.1111/j.1365‑2141.2004.05257.x 15606558
    [Google Scholar]
  9. Mari G. Deter R.L. Carpenter R.L. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. N. Engl. J. Med. 2000 342 1 9 14 10.1056/NEJM200001063420102 10620643
    [Google Scholar]
  10. Wanapirak C Muninthorn W Sanguansermsri T Dhananjayanonda P Tongsong T Prevalence of thalassemia in pregnant women at Maharaj Nakorn Chiang Mai Hospital. Journal of the Medical Association of Thailand = Chotmaihet thangphaet 2004 87 12 1415 1418
    [Google Scholar]
  11. Chui D.H. Alpha-thalassemia: Hb H disease and Hb Barts hydrops fetalis. Ann. N. Y. Acad. Sci. 2005 1054 25 32 10.1196/annals.1345.004 16339648
    [Google Scholar]
  12. Chui D.H. Fucharoen S. Chan V. Hemoglobin H disease: not necessarily a benign disorder. Blood 2003 101 3 791 800 10.1182/blood‑2002‑07‑1975 12393486
    [Google Scholar]
  13. Thammavong K Luewan S Wanapirak C Tongsong T. Ultrasound Features of Fetal Anemia Lessons From Hemoglobin Bart Disease. Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine 2020
    [Google Scholar]
  14. Schrier S.L. Mohandas N. Globin-chain specificity of oxidation-induced changes in red blood cell membrane properties. Blood 1992 79 6 1586 1592 10.1182/blood.V79.6.1586.1586 1547347
    [Google Scholar]
  15. Schrier SL Centis F Verneris M Ma L Angelucci E The role of oxidant injury in the pathophysiology of human thalassemias. Redox report : communications in free radical research 2003 8 5 241 245 10.1179/135100003225002835
    [Google Scholar]
  16. Mohamed Y.A. Meabed M.H. Ashraf A. Morgan D.S. Abdul Latif M.G. Abd-Elkareem R.M. Randomized controlled trial of effect of N-acetylcysteine as an antioxidant on iron overload in children with thalassemia major. Clinal and experimental pediatrics 2020
    [Google Scholar]
  17. Milne G.L. Musiek E.S. Morrow J.D. F2-isoprostanes as markers of oxidative stress in vivo: an overview. Biomarkers 2005 10 Suppl. 1 S10 S23 10.1080/13547500500216546 16298907
    [Google Scholar]
  18. Livrea M.A. Tesoriere L. Pintaudi A.M. Oxidative stress and antioxidant status in beta-thalassemia major: iron overload and depletion of lipid-soluble antioxidants. Blood 1996 88 9 3608 3614 10.1182/blood.V88.9.3608.bloodjournal8893608 8896430
    [Google Scholar]
  19. Awadallah S.M. Atoum M.F. Nimer N.A. Saleh S.A. Ischemia modified albumin: an oxidative stress marker in β-thalassemia major. Clin. Chim. Acta 2012 413 9-10 907 910 10.1016/j.cca.2012.01.037 22336636
    [Google Scholar]
  20. Aukrust P. Ueland T. Lien E. Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am. J. Cardiol. 1999 83 3 376 382 10.1016/S0002‑9149(98)00872‑8 10072227
    [Google Scholar]
  21. Tsutamoto T. Wada A. Matsumoto T. Relationship between tumor necrosis factor-alpha production and oxidative stress in the failing hearts of patients with dilated cardiomyopathy. J. Am. Coll. Cardiol. 2001 37 8 2086 2092 10.1016/S0735‑1097(01)01299‑2 11419892
    [Google Scholar]
  22. Wykretowicz A. Furmaniuk J. Smielecki J. The oxygen stress index and levels of circulating interleukin-10 and interleukin-6 in patients with chronic heart failure. Int. J. Cardiol. 2004 94 2-3 283 287 10.1016/j.ijcard.2003.06.001 15093994
    [Google Scholar]
/content/journals/cmm/10.2174/1573405617666210204211744
Loading
Oxidative Stress and Inflammatory Markers of Cordocentesis Blood in Response to Fetal Anemia
Bentham Science Publishers ; https://doi.org/10.2174/1573405617666210204211744
/content/journals/cmm/10.2174/1573405617666210204211744
/content/journals/cmm/10.2174/1573405617666210204211744
Loading

Data & Media loading...


  • Article Type:     Research Article
Keywords: Alpha-thalassemia ; inflammatory marker ; oxidative stress marker ; hemoglobin Bart’s disease ; fetal anemia

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test